BSE filing, NSE: RELAXO. Summary written from the filing by ALFA Finder's alert engine.
Relaxo Footwears Ltd: key numbers
- Share price
- ₹280.30
- Market cap
- ₹6,978 Cr
- Revenue (annual)
- ₹2,702 Cr
- Net profit (annual)
- ₹179.3 Cr
- P/E (TTM)
- 37.6×Sector 62.0×
- Promoter holding
- 71.27%+0.00% QoQ
- FII holding
- 2.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Relaxo Footwears Ltd
All →Relaxo Footwears Acquisition
Relaxo Footwears acquired 26% of Clean Max MUOI Private Limited, which becomes an associate. The stake supports renewable energy procurement for its Haryana manufacturing facilities.
Relaxo Footwears Other Announcement
Relaxo Footwears Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Relaxo Footwears Acquisition
Relaxo Footwears executed definitive agreements with Clean Max MUOI to procure renewable energy for its Haryana manufacturing facilities under a group captive mechanism.
Relaxo Footwears Management Change
Relaxo Footwears Limited announced the resignation of Mr. Ankit Jain as Company Secretary and Compliance Officer. He will be relieved from his duties effective November 03, 2026.
Relaxo Footwears Annual General Meeting
Relaxo Footwears Limited held its 42nd Annual General Meeting on September 24, 2026. The meeting discussed financial statements, dividends, and director re-appointments.
Relaxo Footwears Other Announcement
Relaxo Footwears Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. This report forms an integral part of its annual regulatory disclosures.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.